Doris Nnenna Amuji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Doris Nnenna Amuji has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Faith Chinasaokwu Nnaji
Department of Biochemistry, College of Science and Technology, Covenant University, Ota, Ogun State, Nigeria; Covenant Applied Informatics and Communication - Africa Centre of Excellence (CApIC-ACE), Covenant University, Ota, Ogun State, Nigeria
2 shared publications - Suleiman Zakari
Department of Biochemistry, Covenant University, Ota, Ogun, Nigeria, covenantuniversity.edu.ng
2 shared publications - Abimbola Mary Oluwajembola
Department of Biochemistry, College of Science and Technology, Covenant University, Ota, Ogun state, Nigeria
1 shared publication Ayomikun Joshua Pirisola
Department of Biochemistry, College of Science and Technology, Covenant University, Ota, Ogun State, Nigeria; Covenant Applied Informatics and Communication - Africa Centre of Excellence (CApIC-ACE), Covenant University, Ota, Ogun State, Nigeria
1 shared publicationEmeka E. J. Iweala
Department of Biochemistry, College of Science and Technology, Covenant University, Ota, Ogun state, Nigeria
1 shared publicationEmeka E.J. Iweala
Department of Biochemistry, College of Science and Technology, Covenant University, Ota, Ogun State, Nigeria; Covenant Applied Informatics and Communication - Africa Centre of Excellence (CApIC-ACE), Covenant University, Ota, Ogun State, Nigeria
1 shared publication
Latest Publications
- Open Access
- 16 July 2026
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 48, 101325
BRK/PTK6 in breast cancer: prognostic and therapeutic significance
- 16 July 2026
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 48, 101325
Open AccessBRK/PTK6 in breast cancer: prognostic and therapeutic significance
- Open Access
- 14 March 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Association of MET gene polymorphisms with breast cancer risk in Nigerian patients: a case–control study
Breast cancer (BC) is a major cause of cancer-related mortality among women worldwide. Genetic polymorphisms, such as those in the Mesenchymal Epithelial T
- 14 March 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessAssociation of MET gene polymorphisms with breast cancer risk in Nigerian patients: a case–control study
Breast cancer (BC) is a major cause of cancer-related mortality among women worldwide. Genetic polymorphisms, such as those in the Mesenchymal Epithelial T
- Open Access
- 30 December 2025
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 46, 101089
Unraveling the potential of USP8 as a therapeutic target for overcoming c-Met-mediated resistance in breast cancer: A review
- 30 December 2025
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 46, 101089
Open AccessUnraveling the potential of USP8 as a therapeutic target for overcoming c-Met-mediated resistance in breast cancer: A review
- Open Access
- 30 December 2024
- Published by Umaru Musa YarAdua University Katsina NG in UMYU Scientifica
- Vol. 3 (4) , 67-83
Review of Magnetic Nanoparticles: From Synthesis and Design to Applications
Study’s Excerpt/Novelty Full Abstract It is believed that among others, magnetic nanoparticles possess the ability for stability, biocompatibility, and cost-effectiveness in biomedicine. Despite many types of magnetic materials, including non-noble metals like iron, cobalt, and nickel, the potential applications seem not to have been as explored as with noble metals like gold. This review aimed to give a broad overview of magnetic nanoparticles, more so their synthesis, characterization, and various applications in disease detection, such as cancer diagnostics. This was a literature review design; the data were sourced from peer-reviewed articles published within the last ten years. The criteria for selecting studies included that they had to directly address magnetic nanoparticle synthesis, design, and application. For this purpose, databases such as PubMed, Scopus, and Google scholar were tapped into to ensure the widest possible relevant coverage. Different approaches, such as chemical or mechanical ones, are used to create magnetic nanoparticles. The paper outlines the advantages of magnetic nanoparticles in the treatment of diseases. Furthermore, as most of the categorization techniques now in use are found to be inaccurate and unreliable, they have now shown certain flaws. Therefore, the use of magnetic nanoparticles in biomedical applications, especially in diagnosing and treating diseases, holds great promise. However, improvement in the methodology for the classification of nanoparticles is quite necessary. Such standard protocols for synthesizing and characterizing magnetic nanoparticles should be developed in the near future, with new therapeutic applications being explored in this domain.
- 30 December 2024
- Published by Umaru Musa YarAdua University Katsina NG in UMYU Scientifica
- Vol. 3 (4) , 67-83
Open AccessReview of Magnetic Nanoparticles: From Synthesis and Design to Applications
Study’s Excerpt/Novelty Full Abstract It is believed that among others, magnetic nanoparticles possess the ability for stability, biocompatibility, and cost-effectiveness in biomedicine. Despite many types of magnetic materials, including non-noble metals like iron, cobalt, and nickel, the potential applications seem not to have been as explored as with noble metals like gold. This review aimed to give a broad overview of magnetic nanoparticles, more so their synthesis, characterization, and various applications in disease detection, such as cancer diagnostics. This was a literature review design; the data were sourced from peer-reviewed articles published within the last ten years. The criteria for selecting studies included that they had to directly address magnetic nanoparticle synthesis, design, and application. For this purpose, databases such as PubMed, Scopus, and Google scholar were tapped into to ensure the widest possible relevant coverage. Different approaches, such as chemical or mechanical ones, are used to create magnetic nanoparticles. The paper outlines the advantages of magnetic nanoparticles in the treatment of diseases. Furthermore, as most of the categorization techniques now in use are found to be inaccurate and unreliable, they have now shown certain flaws. Therefore, the use of magnetic nanoparticles in biomedical applications, especially in diagnosing and treating diseases, holds great promise. However, improvement in the methodology for the classification of nanoparticles is quite necessary. Such standard protocols for synthesizing and characterizing magnetic nanoparticles should be developed in the near future, with new therapeutic applications being explored in this domain.
- Open Access
- 22 October 2024
- Published by Elsevier in Current Research in Pharmacology and Drug Discovery
- Vol. 7, 100204
Targeting c-Met in breast cancer: From mechanisms of chemoresistance to novel therapeutic strategies
- 22 October 2024
- Published by Elsevier in Current Research in Pharmacology and Drug Discovery
- Vol. 7, 100204
Open AccessTargeting c-Met in breast cancer: From mechanisms of chemoresistance to novel therapeutic strategies
- Open Access
- 4 July 2024
- Published by Elsevier in Scientific African
- Vol. 25
Protein biomarkers for diagnosis of breast cancer
- 4 July 2024
- Published by Elsevier in Scientific African
- Vol. 25
Open AccessProtein biomarkers for diagnosis of breast cancer